NEW DRUGS 2014 NEW DRUGS AND MEDICAL ISSUES 2014 SAMIR EL ANSARY 1 Zerbaxa (ceftolozane and tazobactam) Injection Company: Cubist Pharmaceuticals, Inc. Date of Approval:…
NEW DRUGS 2014 NEW DRUGS AND MEDICAL ISSUES 2014 SAMIR EL ANSARY 1 Zerbaxa (ceftolozane and tazobactam) Injection Company: Cubist Pharmaceuticals, Inc. Date of Approval:…
NEW DRUGS 2014 NEW DRUGS AND MEDICAL ISSUES 2014 SAMIR EL ANSARY 1 Zerbaxa (ceftolozane and tazobactam) Injection Company: Cubist Pharmaceuticals, Inc. Date of Approval:…
Slide 1Welcome! Please take a moment to complete the short Please take a moment to complete the short pre-program survey in your packet. Your participation will help us assess…
Clinical Interpretation of MICs in the Era of Multidrug Bacterial Resistance Wael E Shams, M.D. Division of Infectious Diseases Department of Internal Medicine James H Quillen…
Development of Drugs for Resistant Pathogens Francis P. Tally M.D. Cubist Pharmaceuticals, Inc. Development of Drugs for Resistant Pathogens Antimicrobials Developed Development…
Slide 1 Clinical Interpretation of MICs in the Era of Multidrug Bacterial Resistance Wael E Shams, M.D. Division of Infectious Diseases Department of Internal Medicine James…